Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 60,711 shares on August 28, 2026, for approximately ₹1.81 Crore. This daily report confirms ongoing share repurchase activity.
- Value
- ₹1.81 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
41 announcements with these filters
Advanced Enzyme Technologies bought back 60,711 shares on August 28, 2026, for approximately ₹1.81 Crore. This daily report confirms ongoing share repurchase activity.
Advanced Enzyme Technologies bought back 72,807 shares at an average price of ₹303.25 each on August 25, 2026. This daily disclosure fulfills regulatory requirements.
Advanced Enzyme Technologies bought back 40,876 shares on August 24, 2026, at an average price of ₹302.78 per share. This is part of its ongoing buyback program.
Advanced Enzyme Technologies Ltd repurchased 91,757 equity shares on August 21, 2026, at an average price of ₹305.9378, totaling approximately ₹2.81 Crore.
Advanced Enzyme Technologies Ltd. bought back 88,274 equity shares at an average price of ₹308.7879 per share on August 20, 2026, under its buyback program.
Advanced Enzyme Technologies reported the buyback of 67,748 equity shares on August 19, 2026, at an average price of ₹305.05 per share.
Advanced Enzyme Technologies Ltd bought back 94,686 shares at an average price of ₹305.44 per share on August 18, 2026.
Advanced Enzyme Technologies bought back 65,252 shares on August 17, 2026, at an average price of ₹304.71 per share under its ongoing buyback program.
Advanced Enzyme Technologies bought back 1,10,951 equity shares on August 14, 2026, at an average price of ₹303.80 per share.
Advanced Enzyme Technologies announced an open market buyback of up to 13.94 lakh shares at a maximum price of ₹500 per share.
Advanced Enzyme Technologies Limited's board approved a buyback of up to 1.39 million shares worth ₹69.7 Crore via the open market to optimize capital.